Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is headquartered in Xi'an, China.
Research context
Ginwa Enterprise (Group) Inc appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Ginwa Enterprise (Group) Inc is currently in a long term uptrend where the price is trading 17.7% above its 200 day moving average.
From a valuation standpoint, the stock is 65.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.3.
Ginwa Enterprise (Group) Inc's total revenue sank by 1.9% to $195M since the same quarter in the previous year.
Its net income has increased by 22.7% to $20M since the same quarter in the previous year.
Finally, its free cash flow fell by 40.1% to $10M since the same quarter in the previous year.
Based on the above factors, Ginwa Enterprise (Group) Inc gets an overall score of 3/5.